Regulating vaccines at the FDA: development and licensure of Zika vaccines
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2017-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e64a72e3fb8a47fb95fe06c998f8f0ef | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Marion F. Gruber |e author |
| 700 | 1 | 0 | |a Philip R. Krause |e author |
| 245 | 0 | 0 | |a Regulating vaccines at the FDA: development and licensure of Zika vaccines |
| 260 | |b Taylor & Francis Group, |c 2017-06-01T00:00:00Z. | ||
| 500 | |a 1476-0584 | ||
| 500 | |a 1744-8395 | ||
| 500 | |a 10.1080/14760584.2017.1324304 | ||
| 546 | |a EN | ||
| 690 | |a accelerated approval | ||
| 690 | |a animal rule | ||
| 690 | |a immune response | ||
| 690 | |a infectious disease | ||
| 690 | |a licensure pathways | ||
| 690 | |a surrogate marker | ||
| 690 | |a us fda | ||
| 690 | |a vaccine development | ||
| 690 | |a zika | ||
| 690 | |a vaccine approval process | ||
| 690 | |a Internal medicine | ||
| 690 | |a RC31-1245 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Expert Review of Vaccines, Vol 16, Iss 6, Pp 525-527 (2017) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/14760584.2017.1324304 | |
| 787 | 0 | |n https://doaj.org/toc/1476-0584 | |
| 787 | 0 | |n https://doaj.org/toc/1744-8395 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e64a72e3fb8a47fb95fe06c998f8f0ef |z Connect to this object online. |